Therefore, the results indicated that eriodictyol can attenuate LPS/D-GalN-induced ALI by inhibiting oxidative stress and inflammation through the activation of the PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and acute respiratory distress syndrome.